Table 2.
Feature | Positive | Negative | Not reported | n (%) |
---|---|---|---|---|
Recurrent infections | 77 | - | 1 | 77/78 (98.7) |
Corpus callosum agenesis | 76 | - | 2 | 76/78 (97.4) |
Profound developmental delay | 76 | 1 | 1 | 76/78 (97.4) |
Cutaneous manifestations | 75 | 3 | - | 75/78 (96.2) |
Immune system involvement | 60 | 16 | 2 | 60/78 (76.9) |
Cardiomyopathy | 51 | 18 | 9 | 51/78 (65.4) |
Cataract | 49 | 25 | 4 | 49/78 (62.8) |
Microcephaly | 45 | 15 | 18 | 45/78 (57.7) |
Hypotonia | 37 | - | 41 | 37/78 (47.4) |
Seizures | 26 | 16 | 36 | 26/78 (33.3) |
Growth retardation | 24 | - | 54 | 24/78 (30.8) |